Could new immune drugs replace transplants for leukemia patients?

This study tests whether adding newer antibody-based drugs to standard chemotherapy can improve survival and reduce the need for stem cell transplants in adults with acute lymphoblastic leukemia (ALL). About 1,200 patients aged 18–65 with newly diagnosed ALL will be assigned to one of three groups based on their leukemia subtype. The goal is to see if these newer treatments can control the disease better than current approaches.